Last week, PQA released an important report, Recommendations to Improve the Quality of Oral Anticancer Medication Use, which we believe is a key step towards improving the quality of care of individuals using oral anticancer medications (OAM).
The uniqueness of OAMs, including complex treatment regimens, variable dosing schedules, and temporary and intentional discontinuation of therapy, present distinct challenges to accurately defining and measuring adherence and persistence. PQA will use our research and measurement expertise to explore OAM adherence or persistence methodologies to inform potential development of a health plan measure. Learn more about this report below.
We also highlight our members' perspectives on research partnerships, access to CGM services, and supporting education and adherence. If you have news you'd like for us to spotlight in an upcoming Five For Friday, send us an email!